Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

Age greater than or equal to (\>=)18 years.
Participants who are initiate treatment or will be treated with Fruzaqla according to the approved label of South Korea.
Participant voluntarily consent to participate in the study.

Participants for whom Fruzaqla is contraindicated or those with risks that should avoid starting Fruzaqla, as per the product label.
Participants actively participating in other interventional clinical trial(s) on mCRC treatments.
Pregnant or breastfeeding women.

A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea